Cours A.P. Pharma, Inc. Other OTC
Actions
US00202J2033
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
CA 2024 * | 148 M 133 M | CA 2025 * | 178 M 160 M | Capitalisation | 417 M 375 M |
---|---|---|---|---|---|
Résultat net 2024 * | -14 M -12,58 M | Résultat net 2025 * | 1 M 898 k | VE / CA 2024 * | 2,82 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 2,35 x |
PER 2024 * |
-30,8
x | PER 2025 * |
415
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 99,3% |
Dernier transcript sur A.P. Pharma, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16/06/23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/11/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20/09/21 |
Craig Johnson
BRD | Director/Board Member | 62 | 13/01/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+16,59% | 44,44 Md | |
+41,98% | 40,03 Md | |
-10,62% | 37,68 Md | |
+29,92% | 31,46 Md | |
-9,23% | 27,29 Md | |
+12,34% | 26,29 Md | |
+41,53% | 13,8 Md | |
+31,49% | 12,46 Md | |
-7,40% | 11,26 Md |
- Bourse
- Actions
- Action HRTX
- Action